MK-7622 is used as adjunctive therapy to acetylcholinesterase inhibitors (AChEIs) for the symptomatic treatment of participants with mild to moderate Alzheimer's Disease (AD). Now MK-7622 is in phase II clinical trials by Merck.
仅供研究使用。 我们不向患者出售。
Name | MK7622 |
---|---|
Iupac Chemical Name | 3-[(1S,2S)-2-Hydroxycyclohexyl]-6-[(6-methyl-3-pyridinyl)methyl]benzo[h]quinazolin-4(3H)-one |
Synonyms | MK-7622;MK 7622 |
英文同义词 | MK-7622;MK 7622 |
Molecular Formula | C25H25N3O2 |
Molecular Weight | 399.48 |
Smile | O=C1N([C@@H]2[C@@H](O)CCCC2)C=NC3=C1C=C(CC4=CC=C(C)N=C4)C5=CC=CC=C53 |
InChiKey | JUVQLZBJFOGEEO-GOTSBHOMSA-N |
InChi | InChI=1S/C25H25N3O2/c1-16-10-11-17(14-26-16)12-18-13-21-24(20-7-3-2-6-19(18)20)27-15-28(25(21)30)22-8-4-5-9-23(22)29/h2-3,6-7,10-11,13-15,22-23,29H,4-5,8-9,12H2,1H3/t22-,23-/m0/s1 |
CAS Number | 1227923-29-6 |
相关CAS号 |
包装 | Price | 库存 | Purity | 备货期 |
---|---|---|---|---|
大货 | Enquiry | Enquiry | Enquiry |
外观性状 | light-yellow solid to off-white solid |
---|---|
Purity | 98% by HPLC |
Storage | 3 years -20ºCpowder;6 months-80ºCin solvent |
Solubility | Soluble in DMSO |
处理方式 | |
Shipping Condition | Shipped under ambient temperature. |
海关编码 |
Targets | |
---|---|
Mechanism | |
Cell study | |
Animal study | |
Clinical study |